Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, has received a key patent from the US Patent and Trademark Office (USPTO) for a lipid preparation use method.
The patent covers a method for enhancing dietary calcium absorption, bone formation, and bone mass maximization in non-infant children or adults, by administrating routinely a dietary supplement or food article that comprises the lipid preparation of the invention.
"We are very pleased to be granted a patent, which we believe validates our research and development efforts and enhances our future products value proposition," said Dr Ariel Katz, president and chief executive officer of Enzymotec Ltd. "The potential market for such products is large and growing, and we will continue to invest in innovation to bring the highest quality nutritional ingredients to our customers."
The Company has been granted over 50 patents and has applications for about 100 additional patents pending worldwide.
Enzymotec develops, manufactures and markets innovative bio-functional lipid ingredients, as well as final products, based on sophisticated processes and technologies.